Lataa...
Current Status on Therapeutic Molecules Targeting Siglec Receptors
The sialic acid-binding immunoglobulin-type of lectins (Siglecs) are receptors that recognize sialic acid-containing glycans. In the majority of the cases, Siglecs are expressed on immune cells and play a critical role in regulating immune cell signaling. Over the years, it has been shown that the s...
Tallennettuna:
| Julkaisussa: | Cells |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7765293/ https://ncbi.nlm.nih.gov/pubmed/33333862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9122691 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|